John R Subjeck Selected Research

glucose-regulated protein 170

1/2018	Creation of Recombinant Chaperone Vaccine Using Large Heat Shock Protein for Antigen-Targeted Cancer Immunotherapy.
1/2014	The Endoplasmic Reticulum Chaperone GRP170: From Immunobiology to Cancer Therapeutics.
12/2013	Enhanced endoplasmic reticulum entry of tumor antigen is crucial for cross-presentation induced by dendritic cell-targeted vaccination.
8/2013	High molecular weight stress proteins: Identification, cloning and utilisation in cancer immunotherapy.
4/2013	A multifunctional chimeric chaperone serves as a novel immune modulator inducing therapeutic antitumor immunity.
6/2010	Superior antitumor response induced by large stress protein chaperoned protein antigen compared with peptide antigen.
8/2006	Extracellular targeting of endoplasmic reticulum chaperone glucose-regulated protein 170 enhances tumor immunity to a poorly immunogenic melanoma.
1/2004	Development of cancer vaccines using autologous and recombinant high molecular weight stress proteins.
6/2003	Immunization with tumor-derived ER chaperone grp170 elicits tumor-specific CD8+ T-cell responses and reduces pulmonary metastatic disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

John R Subjeck Research Topics

Disease

36	Neoplasms (Cancer) 01/2022 - 01/2002
9	Melanoma (Melanoma, Malignant) 01/2022 - 06/2003
5	Neoplasm Metastasis (Metastasis) 01/2014 - 06/2003
4	Atherosclerosis 01/2015 - 05/2007
4	Infections 04/2012 - 06/2006
3	Carcinoma (Carcinomatosis) 04/2006 - 08/2002
2	Experimental Melanoma 04/2013 - 09/2011
2	Renal Cell Carcinoma (Grawitz Tumor) 09/2010 - 07/2007
1	Hepatitis 01/2013
1	Prostatic Neoplasms (Prostate Cancer) 11/2012
1	Shock 04/2012
1	Alzheimer Disease (Alzheimer's Disease) 04/2012
1	Pathologic Processes 04/2012
1	Vesicular Stomatitis 04/2011
1	Virus Diseases (Viral Diseases) 04/2011
1	Hypoxia (Hypoxemia) 12/2008
1	Communicable Diseases (Infectious Diseases) 06/2006
1	Fever (Fevers) 06/2006
1	Breast Neoplasms (Breast Cancer) 04/2006
1	Necrosis 01/2005
1	Hyperthermia 01/2002

Drug/Important Bio-Agent (IBA)

19	VaccinesIBA 01/2022 - 01/2002
15	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2018 - 01/2002
13	AntigensIBA 01/2020 - 03/2002
12	Proteins (Proteins, Gene)FDA Link 01/2018 - 03/2002
9	glucose-regulated protein 170IBA 01/2018 - 06/2003
7	Scavenger Receptors (Scavenger Receptor)IBA 01/2015 - 05/2007
5	Neoplasm Antigens (Tumor Antigens)IBA 01/2014 - 03/2006
4	Molecular Chaperones (Chaperone, Molecular)IBA 01/2018 - 01/2004
3	CytokinesIBA 11/2012 - 01/2005
3	Peptides (Polypeptides)IBA 07/2007 - 01/2002
3	Cancer VaccinesIBA 08/2006 - 08/2002
2	FlagellinIBA 01/2021 - 04/2013
2	Carbonic Anhydrase IXIBA 12/2008 - 07/2007
2	Immunologic Adjuvants (Immunologic Adjuvant)IBA 01/2005 - 10/2003
1	Pattern Recognition ReceptorsIBA 01/2021
1	Pathogen-Associated Molecular Pattern MoleculesIBA 01/2021
1	Adrenergic Receptors (Adrenergic Receptor)IBA 01/2020
1	Adrenergic Agents (Adrenergic Drugs)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2015
1	Biological ProductsIBA 01/2014
1	Synthetic Vaccines (Recombinant Vaccines)IBA 01/2014
1	InterleukinsIBA 04/2013
1	Concanavalin AIBA 01/2013
1	CPG-oligonucleotideIBA 04/2012
1	Antiviral Agents (Antivirals)IBA 04/2011
1	Toll-Like Receptor 3IBA 04/2011
1	EpitopesIBA 06/2010
1	Protein Subunit VaccinesIBA 06/2010
1	Toll-Like Receptors (Toll-Like Receptor)IBA 06/2009
1	Naphazoline (All Clear)FDA LinkGeneric 12/2008
1	Interleukin-2 (IL2)IBA 12/2008
1	HSP110 Heat-Shock ProteinsIBA 07/2007
1	Lipoproteins (Lipoprotein)IBA 05/2007
1	LipopolysaccharidesIBA 05/2007
1	Vaccine AdjuvantsIBA 06/2006
1	Chemokine CCL5IBA 04/2006
1	Cell Surface ReceptorsIBA 01/2005
1	Immunoglobulin G (IgG)IBA 10/2003
1	Therapeutic UsesIBA 06/2003
1	Complementary DNA (cDNA)IBA 08/2002
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 08/2002
1	glucose-regulated proteinsIBA 01/2002

Therapy/Procedure

12	Immunotherapy 01/2021 - 01/2002
4	Therapeutics 01/2014 - 12/2008
2	Radiotherapy 01/2020 - 11/2012